FDA approval for tiny implant that preserves vision in rare genetic eye disease

Published on October 30, 2025
Encelto has become the first US Food and Drug Administration-approved treatment for macular telangiectasia type 2 (MacTel)
Continue reading on website
Other news

So you want to create a private label eyewear brand? | Optometry Times - Clinical News

October 30, 2025
A discussion with company executives who specialize in helping optometrists and optical shops design and launch their own branded frame collections.

The AOA Foundation announces new Silhouette Scholarship | Optometry Times - Clinical News

October 30, 2025
New partner of the foundation, The Silhouette Group, will offer sustainability-focused scholarship.